Everything below concerns bremelanotide. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-02-23. Numbers and descriptions here follow the published literature rather than marketing material.
Bremelanotide is a synthetic cyclic heptapeptide developed as an analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation and appetite signalling. Its structure contains seven amino acid residues joined by a lactam bridge that closes the ring between two side chains. The molecular formula is C50H68N14O10 and the nominal molecular mass is near 1025 daltons. Much of the early laboratory literature refers to the same molecule by the development code PT-141.
The compound emerged from a research programme examining melanocortin analogues for effects on skin pigmentation. During early human studies, participants reported spontaneous erections as an unexpected side effect, which redirected development toward sexual function rather than tanning. An intranasal formulation was investigated in clinical trials but did not reach market approval. A subcutaneous injectable version later completed the regulatory process, and the nasal route does not appear in approved labelling.
Approved use is narrow and jurisdiction-specific. In the United States, the injectable product is authorised for premenopausal women with acquired, generalised hypoactive sexual desire disorder, a diagnosis that requires documented distress. It is not approved for men, for postmenopausal women, or for use alongside hormonal contraceptives under the approved labelling. Outside regulated markets, the same peptide is frequently sold as a research chemical, where identity, purity, and sterility are not independently verified.
Early research on PT-141 grew out of work on melanotan II, a related cyclic peptide studied for pigmentation. Investigators observed that centrally acting melanocortin agonists also influenced sexual behaviour in animal models, and the programme shifted toward that endpoint. A nasal formulation was evaluated in clinical trials but showed inconsistent absorption, and later studies used subcutaneous administration instead. Regulatory approval in the United States followed in 2019 for a defined population of premenopausal women with acquired, generalised hypoactive sexual desire disorder. That approval was specific to that group rather than a broad indication.
Bremelanotide acts as a non-selective agonist at melanocortin receptors, with reported activity at MC1R, MC3R, MC4R and MC5R. The proposed basis for its central effects is activation of MC4R populations in the hypothalamus, a region associated with appetite and reproductive signalling. Because the peptide carries a net positive charge and polar side chains, it does not cross biological membranes freely, which is one reason oral administration is not the standard route. Effects generally appear within an hour of parenteral administration and are described as centrally mediated rather than peripheral.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C50H68N14O10 | Cyclic heptapeptide backbone |
| Molecular mass | Approximately 1025 Da | Nominal mass of the free peptide |
| Appearance | White to off-white lyophilised powder | Typical for purified synthetic peptides |
| Solubility class | Freely soluble in water | Organic solubility is limited |
| Typical storage temperature | −20 °C or below | Protect from moisture and light |
Lyophilised peptide is generally held below minus twenty degrees Celsius, protected from light and moisture, because hydrolysis and oxidation accumulate faster at ambient temperature. Once reconstituted, solutions are typically kept between two and eight degrees Celsius and used within a short window defined by the supplier. Repeated freeze-thaw cycles are avoided since they promote aggregation and loss of soluble material. Container material matters as well, because peptides adsorb to certain plastics and glass surfaces at low concentration. Stability figures supplied by a vendor apply only to the specific lot and buffer that were tested.
Identity and purity are usually established with reversed-phase high-performance liquid chromatography combined with mass spectrometry. A gradient of water and acetonitrile containing trifluoroacetic acid is a common mobile phase, and ultraviolet detection near 214 nanometres responds to the peptide backbone. Mass spectrometry confirms the expected molecular mass and helps reveal truncation or oxidation products. Purity is reported as a peak-area percentage, a figure that depends on the wavelength and gradient used, so values from different laboratories are not always directly comparable. Peptide mapping and amino acid analysis provide additional confirmation when required.
Regulatory status varies by jurisdiction, where approved prescription products, compounded preparations and research-grade material are treated as distinct categories with different documentation requirements. Suppliers of research material commonly issue a certificate of analysis listing purity, identity and sometimes endotoxin content. Independent verification by a third-party laboratory is often recommended because self-reported figures are difficult to check. Literature discussions usually state the source, purity and storage conditions of the material used, since these details affect reproducibility. Analysts note that a reported purity figure does not by itself describe biological activity.
Lyophilized peptide material is generally stored at -20 °C or below to limit degradation, while reconstituted solutions are less stable and are typically kept refrigerated and protected from light. Repeated freeze-thaw cycles can accelerate aggregation and should be minimized. Stability for any specific lot depends on purity, moisture content, and packaging. Handling in a temperature-controlled environment reduces variability across replicates, and exposure to ambient humidity during weighing can introduce error. Aliquotting reduces the number of times a stock container is opened.
Reverse-phase high-performance liquid chromatography is the standard method for assessing purity. Mass spectrometry confirms molecular identity and detects sequence variants or truncation products. Ultraviolet absorbance at 214 or 280 nm is used for quantification, with the choice depending on the peptide sequence. Method validation typically addresses linearity, limit of detection, and precision across a defined concentration range. Impurity profiling may also employ ion-exchange or size-exclusion chromatography, and these techniques complement one another.
Certificate of analysis documents usually report purity percentage, molecular weight, and appearance. Researchers verify identity by comparing observed and theoretical mass values. Chain-of-custody records and batch numbers help trace material from source to experiment. Independent verification of supplier claims is considered good practice when material identity is critical to a study. Records should include the storage history of each aliquot, and unexpected deviations in appearance or solubility warrant re-testing before use.
PT-141 is the research code for bremelanotide, a cyclic heptapeptide derived from alpha-melanocyte-stimulating hormone. The molecule belongs to the melanocortin receptor agonist family and shows highest affinity for the MC4 receptor subtype, with weaker activity at MC1, MC3 and MC5. Its structure retains the core His-Phe-Arg-Trp sequence that defines melanocortin recognition, while cyclization and terminal modifications improve metabolic stability relative to the parent hormone. Early work classified the compound as a centrally acting agent rather than a peripherally acting vasodilator, which shaped subsequent development priorities.
Receptor activation in hypothalamic and limbic circuits is the mechanism most often cited for the observed effects on sexual desire. Signalling through MC4R couples to Gs proteins and raises intracellular cyclic AMP, which in turn modulates dopaminergic tone in reward-related pathways. Because the peptide reaches the central nervous system after subcutaneous administration, peripheral vascular changes are regarded as secondary rather than primary. The precise neural circuits that translate receptor occupancy into behavioural change remain incompletely mapped, and published accounts describe the pathway in general terms rather than as a fully resolved sequence.
=== Economics === In 2007, paroxetine was ranked 94th on the list of bestselling drugs, with over $1 billion in sales. In 2006, paroxetine was the fifth-most prescribed antidepressant in the U.S. retail market, with more than 19.7 million prescriptions. In 2007, sales had dropped slightly to 18.1 million but paroxetine remained the fifth-most prescribed antidepressant in the U.S.
=== Speculative technologies === Some other human enhancement technologies are still speculative, such as: mind uploading, exocortex, and endogenous artificial nutrition. Mind uploading is the hypothetical process of "transferring"/"uploading" or copying a conscious mind from a brain to a non-biological substrate by scanning and mapping a biological brain in detail and copying its state into a computer system or another computational device. The exocortex can be defined as a theoretical artificial external information processing system that would augment a brain's biological high-level cognitive processes. Endogenous artificial nutrition can be similar to having a radioisotope generator that resynthesizes glucose (similarly to photosynthesis), amino acids and vitamins from their degradation products, theoretically availing for weeks without food if necessary. Nick Bostrom listed some additional capabilities that are expected to be physically possible in theory, given a sufficient technological level, such as:
HON=NOH + 2 NADH + 2 H+ This systematic name of this enzyme class hydroxylamine:NAD+ oxidoreductase. It is also called NADH2:hyponitrite oxidoreductase. This enzyme belongs to the family of oxidoreductases, specifically those acting on other nitrogenous compounds as donors with NAD+ or NADP+ as acceptor. It employs one cofactor, metal.
== Efficacy == The use of lasers in treating periodontal disease has been seen by some dental professionals as controversial. The American Academy of Periodontology stated in 1999 that it was "not aware of any randomized blinded controlled longitudinal clinical trials, cohort or longitudinal studies, or case-controlled studies indicating that 'laser excisional new attachment procedure (or Laser ENAP)' or 'laser curettage' offers any advantageous clinical result not achieved by traditional periodontal therapy. Moreover, published studies suggest that use of lasers for ENAP procedures and/or gingival curettage could render root surfaces and adjacent alveolar bone incompatible with normal cell attachment and healing." A 2015 systematic review from the AAP regeneration workshop acknowledged peer-reviewed studies reporting periodontal regeneration, and further suggested that the LANAP protocol's minimally invasive nature may offer advantages in the regeneration of defects where minimal soft tissue change is required. The AAP consumer information page on laser therapy for gum disease notes that lasers can be used to treat periodontal disease and that controlled studies have reported similar results to some other treatment options (including scaling and root planing alone), and also states that different laser wavelengths have different applications in periodontal treatment.
Sources: en.wikipedia.org
=== Independent Grand Lodge of Colon === At the insistence of Albert Pike (after he had been allowed to return from exile to the United States), in 1867, the Grand Lodge of Colon under the leadership of Grand Master Andrés Puente, established its own constitution. Even though they recognized the sovereignty of the Supreme Council, their new constitution established that the Grand Lodge of Colon held the exclusive authority to enact its own bylaws, issue charters, and regulate its own Lodges. Albert Pike gave his staunch support and approval in the new autonomy of the Grand Lodge. The Supreme Council of the Scottish Rite in Cuba, however, outright refused to recognize any independent authority of the Grand Lodge of Colon. They dissolved the Grand Lodge and assumed all of its orders. On September 20, 1867, the Grand Lodge of Colon agreed to suspend their constitution until a joint meeting of the Supreme Council and the Grand Lodge could occur, where the parties were scheduled to discuss the situation. That meeting was scheduled to happen on November 25, 1868. That meeting never took place, due to the outbreak of the Ten Years' War.
compared four sterile wound-cleansing solutions (saline, Ringer's solution, Prontosan® and Octenisept®) using a wound coating model consisting of slides containing dried blood plasma or fibrin. The concentration of dissolved proteins was measured and the findings indicate that a surfactant containing solution (polyhexamethylene biguanide with betaine) (Prontosan®) was more effective than saline in removing the protein (adhered dried plasma or fibrin). The proteins in the antiseptic solution (Octenisept®) were denatured and became insoluble. The authors suggest this implies that the antiseptic solution is unsuitable as a 'general' wound cleanser and that its use should be restricted to infected wounds. In a double-blind, randomised, stratified, controlled, parallel-group study the influence of two antiseptics (octenidine, polyhexanide) versus a placebo of Ringer's solution on wound healing in a porcine model was conducted. Assessment of healing was recorded using planimetry and histopathology. At nine days post wounding, the octenidine-treated wounds demonstrated retarded contraction at significantly greater extent than placebo and polyhexanide. At days 18 and 28 the polyhexanide treated wounds supported contraction significantly more than placebo and octenidine. The polyhexanide treated wounds led to complete wound closure after 22.9 days, in comparison to the placebo octenidine treated wounds respectively, 24.1 days (p < 0.05) and 28.3 days (no statistical difference to placebo).
As sugar could not have been easily formed under the extreme environment of early Earth, it has been suggested that certain sugars may have originated from space. Astronomers postulate that asteroids delivered sugars to Earth, or sugars were always present in the Solar System. In 2000, astronomers detected glycolaldehyde—a sugar-like molecule—in interstellar space. True sugar was first collected from an asteroid in 2019. Sugar was also detected in a sample collected from the asteroid 101955 Bennu in 2020. In 2026, erythrulose—a tetrose monosaccharide—was detected in dust grains of a molecular cloud near the center of the Milky Way, marking the first time a sugar molecule was found in interstellar space. The identification of erythrulose in galactic dust indicates its possible involvement in forming sugar-containing nucleic acids during the origin of life on Earth about four billion years ago.
Sources: en.wikipedia.org
=== Doping in sport === Phenylpiracetam has stimulant effects and may be used as a doping agent in sport. As a result, it is on the list of stimulants banned for in-competition use by the World Anti-Doping Agency (WADA). This list is applicable in all Olympic sports. Owing to its unique stimulant properties among racetams, phenylpiracetam is the only racetam on the WADA prohibited list.
In June 2018, Carrey was cast as Doctor Robotnik, the main antagonist of the Sonic the Hedgehog video game series, in a film adaptation of the franchise. The film was released in February 2020 to positive reviews. Carrey's portrayal of Ivo Robotnik was praised, with some considering it one of his best performances in years. Carrey returned for Sonic the Hedgehog 2, released in April 2022, which grossed $72 million at the US box office in its opening weekend to give Carrey the best opening of his career to date. In 2020, Carrey and novelist Dana Vachon published Memoirs and Misinformation, a surrealist novel with elements of autobiography starring a fictionalized version of Carrey. In September, during the final stages of the 2020 U.S. presidential election, it was announced that Carrey would portray presidential nominee Joe Biden on the 46th season of Saturday Night Live, taking over the role from Jason Sudeikis, Woody Harrelson and John Mulaney. However, many felt Carrey's high-energy comedy style clashed with the real-life Biden's low-key persona, producing an imitation that lacked authenticity, and failed to impress viewers and critics. On December 19, 2020, Carrey announced that he would step down from playing Biden on Saturday Night Live, stating that he had a six-week deal. Cast member Alex Moffat succeeded Carrey in portraying Biden during the cold open of the episode hosted by Kristen Wiig on the same day. Carrey appeared as the narrator of the Weeknd's album Dawn FM, released on January 7, 2022.
Meghan Gallacher resigns as the party's deputy leader, citing a "potential risk to the reputation of our party and the leadership contest" after reports that Ross had previously suggested Russell Findlay should succeed him. The government faces questions about the appointment of Emily Middleton to a senior civil service role, as she has been previously linked to previous donations to the Labour Party. A group of MPs call on the government of Azerbaijan to free an academic from the London School of Economics and Political Science who was detained after writing articles critical of the country's environmental policies. British American academic Alan M. Taylor is appointed to the Bank of England's interest rate-setting committee. The UK government confirms that victims of the contaminated blood scandal will begin receiving compensation before the end of the year, with some being entitled to more than £2.5m. 17 August – It is reported that the Register of Members' Interests shows Reform UK leader Nigel Farage as Britain's highest earning MP, with a monthly salary of £96,000 on top of what he is paid as an MP. The majority of his earnings come from his presenting role on GB News. Farage subsequently says the amount is not a monthly sum, but represents presenting and consultancy work done since April. SNP MSP John Mason is stripped of the party whip after a Twitter post in which he said that Israel's actions in Gaza did not amount to "genocide", something a party spokesperson describes as "completely unacceptable".
Sources: en.wikipedia.org
It is a synthetic cyclic peptide that acts as an agonist at melanocortin receptors. It is not a hormone replacement therapy and not a vasodilator in the usual clinical sense, although it does affect vascular tone. Chemically it belongs to the melanocortin analogue family.
PT-141 was the internal development code used during early research and it persists in older publications, conference abstracts, and informal listings. The code and the approved name refer to the same molecule. Its continued use reflects habit in the literature rather than any difference in substance.
No. The intranasal form was studied in trials but was never approved, and absorption through the nasal route varies considerably between individuals. Approved labelling covers a subcutaneous injection only. Any nasal product sold outside regulated channels falls outside verified manufacturing.
PT-141 was the development code used for bremelanotide during its preclinical and early clinical programme. The peptide is now generally referred to by its international nonproprietary name.